Holloway, K, Bennett, T.
Prescription drug misuse among university staff and students: a survey of motives, nature and extend. Drugs Educ Prev Polic
2012; 19: 137–44.
Sheridan, J, Jones, S, Aspden, T.
Prescription drug misuse: quantifying the experiences of New Zealand GPs. J Prim Health Care
2012; 4: 106–12.
Apantaku-Olajide, T, Smyth, BP. Non-medical use of psychotropic prescription drugs among adolescents in substance use treatment. J Psychoactive Drugs
2013; 45: 340–6.
Patterns of benzodiazepine abuse and dependence. Br J Addict
1986; 81: 87–94.
Hajak, G, Muller, WE, Wittchen, HU, Pittrow, D, Kirch, W.
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: review of case reports and epidemiological data. Addiction
2003; 98: 1371–8.
Morton, WA, Stockton, GG. Methylphenidate abuse and psychiatric side effects. Prim Care Companion J Clin Psychiatry
2000; 2: 159–64.
Evans, EA, Sullivan, MA. Abuse and misuse of antidepressants. Subst Abuse Rehabil
2014; 5: 102–20.
Basu, D, Marudkar, M, Khurana, H.
Abuse of neuroleptic drugs by psychiatric patients. Indian J Med Sci
2000; 54: 59–62.
Pierre, JM, Shnayder, I, Wirshing, DA, Wirshing, WC. Intranasal quetiapine abuse [letter]. Am J Psychiatry
2004; 161: 1718.
Hussain, MZ, Waheed, W, Hussain, S.
Intravenous quetiapine abuse [letter to the editor]. Am J Psychiatry
2005; 162: 1755–6.
Morin, AK. Possible intranasal quetiapine misuse. Am J Health Syst Pharm
2007; 64: 723–5.
Reeves, RR, Brister, JC. Additional evidence of the of the abuse potential of quetiapine. South Med J
2007; 100: 834–6.
Reeves, RR. Abuse of olanzapine by substance abusers. J Psychoactive Drugs
2007; 39: 297–9.
Lai, CH. Olanzapine abuse was relieved after switching to aripiprazole in a patient with a psychotic depression [letter]. Prog Neuropsychopharmacol Biol Psychiatry
2010; 34: 1363–4.
Kumsar, NA, Erol, A.
Olanzapine abuse. Subst Abus
2013; 34: 73–4.
WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction
2002; 97: 1183–94.
Pathways to heroin dependence: time to re-appraise self-medication. Addiction
2013; 108: 659–67.
Littrell, KH, Petty, RG, Hilligoss, NM, Peabody, CD, Johnson, CG. Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat
2001; 21: 217–21.
Sattar, SP, Bhatia, SC, Petty, F.
Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci
2004; 29: 452–7.
Hanley, MJ, Kenna, GA. Quetiapine: treatment for substance abuse and drug of abuse. Am J Health Syst Pharm
2008; 65: 611–8.
Brunetti, M, Di Tizio, L, Dezi, S, Pozzi, G, Grandinetti, P, Martinotti, G.
Aripiprazole, alcohol and substance abuse: a review. Eur Rev Med Pharmacol Sci
2012; 16: 1346–54.
Smelson, DA, Losonczy, MF, Davis, CW, Kaune, M, Williams, J, Ziedonis, D.
Risperidone decreases cravings and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry
2002; 47: 671–5.
Drake, RE, Xei, H, McHugo, GJ, Green, AI. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull
2000; 26: 441–9.
Zimmet, SV, Strous, RD, Brugess, ES, Kohnstamm, SAB, Green, AI. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol
2000; 20: 94–9.
Kelly, DL, Gale, EA, Conley, RR. Clozapine treatment in patients with prior substance abuse. Can J Psychiatry
2003; 48: 111–4.
Petrakis, IL, Leslie, D, Finney, JW, Rosenheck, R.
Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia. Am J Addict
2006; 15: 44–9.
Rothschild, AJ (ed). The Evidence-Based Guide to Antipsychotic Medications. American Psychiatric Publishing, 2010.
Smyth, BP, Keenan, E, O'Connor, JJ. Bloodbourne viral infection in Irish injecting drug users. Addiction
1998; 92: 1649–56.
Ryder, N, Cullen, W, Barry, J, Bury, G, Keenan, E, Smyth, BP. Prevalence of problem alcohol use among patients attending primary care for methadone treatment. BMC Fam Pract
2009; 10: 42.
Health Research Board. 2012 Figures from the National Drug-Related Deaths Index. Health Research Board Dublin, 2014.
Santolaria-Fernández, FJ, Gómez-Sirvent, JL, González-Reimers, CE, Batista-López, JN, Jorge-Hernández, JA, Rodríguez-Moreno, F, et al. Nutritional assessment of drug addicts. Drug Alcohol Depend
1995; 38: 11–8.
The challenge of prescription drug misuse: a review and commentary. Pain Med
2005; 6: 152–61.